Literature DB >> 21675615

Review of third and fourth re-excision for narrow or positive margins of invasive and intraductal carcinoma.

Gokulakkrishna Subhas1, Asha J Shah, Aditya Gupta, Jonathan Cook, Linda Dubay, Sumet Silapaswan, Ramachandra Kolachalam, William Kestenberg, Lorenzo Ferguson, Michael J Jacobs, Yousif Goriel, Vijay K Mittal.   

Abstract

The trend in breast surgery has shifted toward breast conservation. We reviewed our third and fourth breast re-excision cases, with an analysis of various factors used in making this decision. A retrospective analysis identified 585 patients who underwent re-excision surgery for positive or close margins of invasive carcinoma or ductal carcinoma in situ (DCIS). Of these patients 75 (13%) and 17 (3%) underwent third and fourth re-excisions, respectively. The indication for a third re-excision was the presence of positive and/or close (< or = 1 mm) margins for invasive carcinoma or DCIS in 72/75 patients. A third re-excision was done 31 days (range 8-123 days) after the second re-excision. Re-excision of margins was done in 45 (60%) patients, whereas 30 (40%) patients underwent mastectomy. Residual tumor mandated a fourth re-excision in 17 patients, which was done 45 days (range 14-87 days) after the third surgery. Re-excision of margins was done in 6 patients, whereas 11 patients underwent mastectomy. Involved or close margins with DCIS were the most common indication for re-excision, accounting for 61/75 (82%) of third and 16/17 (94%) of fourth re-excisions. Histopathology revealed that 28/75 (37%) of third and 7/17 (41%) of fourth re-excision patients had no residual tumor. In conclusion, the majority of re-excisions was done for margins < 1 mm. Lower rates of re-excision were noted in well-differentiated invasive carcinomas. A close or involved DCIS margin was more likely to lead to a third and even a fourth re-excision. The absence of residual tumors in 40% of patients undergoing third and fourth re-excisions calls for a review of margin guidelines for breast re-excision.

Entities:  

Mesh:

Year:  2011        PMID: 21675615     DOI: 10.9738/1340.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  3 in total

1.  Photochemical internalization-mediated delivery of chemotherapeutic agents in human breast tumor cell lines.

Authors:  Marlon S Mathews; Van Vo; En-Chung Shih; Genesis Zamora; Chung-Ho Sun; Steen J Madsen; Henry Hirschberg
Journal:  J Environ Pathol Toxicol Oncol       Date:  2012       Impact factor: 3.567

2.  Costs and effects of intra-operative fluorescence molecular imaging - A model-based, early assessment.

Authors:  Maximilian Präger; Marion Kiechle; Björn Stollenwerk; Christoph Hinzen; Jürgen Glatz; Matthias Vogl; Reiner Leidl
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

3.  Deep learning-based automatic segmentation for size and volumetric measurement of breast cancer on magnetic resonance imaging.

Authors:  Wenyi Yue; Hongtao Zhang; Juan Zhou; Guang Li; Zhe Tang; Zeyu Sun; Jianming Cai; Ning Tian; Shen Gao; Jinghui Dong; Yuan Liu; Xu Bai; Fugeng Sheng
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.